These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3459593)

  • 1. Loss of viability and induction of DNA damage in human leukemic myeloblasts and lymphocytes by m-AMSA.
    Brox LW; Belch A; Ng A; Pollock E
    Cancer Chemother Pharmacol; 1986; 17(2):127-32. PubMed ID: 3459593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
    Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
    Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro.
    Kao-Shan CS; Micetich K; Zwelling LA; Whang-Peng J
    Cancer Treat Rep; 1984; 68(7-8):989-97. PubMed ID: 6204755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
    Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
    Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia.
    Skinner WL; Murray D; Kohli V; Beran M; McCredie KB; Freireich EJ; Andersson BS
    Br J Cancer; 1990 Jan; 61(1):51-5. PubMed ID: 2297490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
    Markovits J; Pommier Y; Kerrigan D; Covey JM; Tilchen EJ; Kohn KW
    Cancer Res; 1987 Apr; 47(8):2050-5. PubMed ID: 3030540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
    Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.
    Pommier Y; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1985 Nov; 24(23):6406-10. PubMed ID: 3002439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative sequestration of m-AMSA in L1210 cells.
    Zwelling LA; Kerrigan D; Michaels S; Kohn KW
    Biochem Pharmacol; 1982 Oct; 31(20):3269-77. PubMed ID: 6897359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA.
    Andersson HC; Kihlman BA
    Carcinogenesis; 1989 Jan; 10(1):123-30. PubMed ID: 2535969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced killing of mammalian cells by radiation combined with m-AMSA.
    Roberts PB; Millar BC
    Br J Cancer; 1980 Nov; 42(5):684-91. PubMed ID: 6893934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
    Pierson V; Pierre A; Pommier Y; Gros P
    Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal activity and kinetic response of cultured human cells to 4'-(9-acridinylamino)methanesulfon-m-anisidine.
    Drewinko B; Yang LY; Barlogie B
    Cancer Res; 1982 Jan; 42(1):107-11. PubMed ID: 6895609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
    Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells.
    Bunch RT; Povirk LF; Orr MS; Randolph JK; Fornari FA; Gewirtz DA
    Biochem Pharmacol; 1994 Jan; 47(2):317-29. PubMed ID: 8304976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
    Pommier Y; Minford JK; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1985 Nov; 24(23):6410-6. PubMed ID: 3002440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
    Andersson BS; Beran M; Bakic M; Silberman LE; Newman RA; Zwelling LA
    Cancer Res; 1987 Feb; 47(4):1040-4. PubMed ID: 3026621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.